The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.
from NYT > Health https://ift.tt/S4XFR5A
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment